Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 Nov;55(11):946–954. doi: 10.1136/thorax.55.11.946

Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis

L Gee 1, J Abbott 1, S Conway 1, C Etherington 1, A Webb 1
PMCID: PMC1745639  PMID: 11050265

Abstract

BACKGROUND—Health related quality of life (HRQoL) measurement is important in determining the impact of disease on daily functioning and subsequently informing interventions. In cystic fibrosis (CF) generic HRQoL measures have been employed but these may not be sufficiently specific. The aim of the current work was to develop and validate a disease specific HRQoL measure for adults and adolescents with cystic fibrosis.
METHODS—Areas of concern to adults and adolescents with CF were identified by unstructured interviews, self-administered questionnaires, consultation with multidisciplinary specialist staff, a review of the relevant literature, and examination of other HRQoL measures. Items for the questionnaire were generated on the basis of this process. Continued evaluation and development of the Cystic Fibrosis Quality of Life (CFQoL) questionnaire was undertaken by a process of statistical analysis and continued feedback from patients. The full testing and validation of the CFQoL questionnaire took place over four phases: (1) initial item generation and testing of a preliminary questionnaire, (2) testing and validation of the second version of the questionnaire, (3) test-retest reliability of a third and final version of the questionnaire, and (4) sensitivity testing of the final version of the questionnaire.
RESULTS—Nine domains of functioning were identified using principal components analysis with varimax rotation. Internal reliability of the identified domains was demonstrated using Cronbach alpha coefficients (range 0.72-0.92) and item to total domain score correlations. Concurrent validity (range r = 0.64-0.74), discriminatory ability between different levels of disease severity, sensitivity across transient changes in health (effect size range, moderate d = 0.56 to large d = 1.95), and test-retest reliability (r =0.74-0.96) were also found to be robust.
CONCLUSIONS—The CFQoL questionnaire is a fully validated disease specific measure consisting of 52 items across nine domains of functioning which have been identified by, and are of importance to, adolescents and adults with cystic fibrosis. This measure will be useful in clinical trials and longitudinal studies.



Full Text

The Full Text of this article is available as a PDF (158.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alonso J., Antó J. M., González M., Fiz J. A., Izquierdo J., Morera J. Measurement of general health status of non-oxygen-dependent chronic obstructive pulmonary disease patients. Med Care. 1992 May;30(5 Suppl):MS125–MS135. doi: 10.1097/00005650-199205001-00011. [DOI] [PubMed] [Google Scholar]
  2. Anderson K. L. The effect of chronic obstructive pulmonary disease on quality of life. Res Nurs Health. 1995 Dec;18(6):547–556. doi: 10.1002/nur.4770180610. [DOI] [PubMed] [Google Scholar]
  3. Barbers R. G. Cystic fibrosis: bilateral living lobar versus cadaveric lung transplantation. Am J Med Sci. 1998 Mar;315(3):155–160. doi: 10.1097/00000441-199803000-00004. [DOI] [PubMed] [Google Scholar]
  4. Brazier J. E., Harper R., Jones N. M., O'Cathain A., Thomas K. J., Usherwood T., Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992 Jul 18;305(6846):160–164. doi: 10.1136/bmj.305.6846.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Busschbach J. J., Horikx P. E., van den Bosch J. M., Brutel de la Rivière A., de Charro F. T. Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest. 1994 Mar;105(3):911–917. doi: 10.1378/chest.105.3.911. [DOI] [PubMed] [Google Scholar]
  6. Creer T. L., Wigal J. K., Kotses H., McConnaughy K., Winder J. A. A life activities questionnaire for adult asthma. J Asthma. 1992;29(6):393–399. doi: 10.3109/02770909209044803. [DOI] [PubMed] [Google Scholar]
  7. Garratt A. M., Ruta D. A., Abdalla M. I., Buckingham J. K., Russell I. T. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993 May 29;306(6890):1440–1444. doi: 10.1136/bmj.306.6890.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jenkinson C., Layte R., Coulter A., Wright L. Evidence for the sensitivity of the SF-36 health status measure to inequalities in health: results from the Oxford healthy lifestyles survey. J Epidemiol Community Health. 1996 Jun;50(3):377–380. doi: 10.1136/jech.50.3.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kaplan R. M., Anderson J. P., Wu A. W., Mathews W. C., Kozin F., Orenstein D. The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis. Med Care. 1989 Mar;27(3 Suppl):S27–S43. doi: 10.1097/00005650-198903001-00003. [DOI] [PubMed] [Google Scholar]
  10. Merrill S. S., Seeman T. E., Kasl S. V., Berkman L. F. Gender differences in the comparison of self-reported disability and performance measures. J Gerontol A Biol Sci Med Sci. 1997 Jan;52(1):M19–M26. doi: 10.1093/gerona/52a.1.m19. [DOI] [PubMed] [Google Scholar]
  11. Orenstein D. M., Nixon P. A., Ross E. A., Kaplan R. M. The quality of well-being in cystic fibrosis. Chest. 1989 Feb;95(2):344–347. doi: 10.1378/chest.95.2.344. [DOI] [PubMed] [Google Scholar]
  12. Piccinelli M., Simon G. Gender and cross-cultural differences in somatic symptoms associated with emotional distress. An international study in primary care. Psychol Med. 1997 Mar;27(2):433–444. doi: 10.1017/s0033291796004539. [DOI] [PubMed] [Google Scholar]
  13. Ruiz M. T., Verbrugge L. M. A two way view of gender bias in medicine. J Epidemiol Community Health. 1997 Apr;51(2):106–109. doi: 10.1136/jech.51.2.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shepherd S. L., Hovell M. F., Slymen D. J., Harwood I. R., Hofstetter C. R., Granger L. E., Kaplan R. M. Functional status as an overall measure of health in adults with cystic fibrosis: further validation of a generic health measure. J Clin Epidemiol. 1992 Feb;45(2):117–125. doi: 10.1016/0895-4356(92)90004-7. [DOI] [PubMed] [Google Scholar]
  15. Super M., Abbott J. Genetic advances in cystic fibrosis: to screen, to treat or both? Disabil Rehabil. 1998 Jun-Jul;20(6-7):202–208. doi: 10.3109/09638289809166730. [DOI] [PubMed] [Google Scholar]
  16. Unruh A. M. Gender variations in clinical pain experience. Pain. 1996 May-Jun;65(2-3):123–167. doi: 10.1016/0304-3959(95)00214-6. [DOI] [PubMed] [Google Scholar]
  17. Yacoub M. H., Banner N. R., Khaghani A., Fitzgerald M., Madden B., Tsang V., Radley-Smith R., Hodson M. Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant. 1990 Sep-Oct;9(5):459–467. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES